Tevogen Inc. has extended its loan agreement with The Patel Family, LLP, allowing it to borrow up to $28.6 million through May 2029, two years longer than the previous term. This loan facility complements Tevogen's existing ATM equity program, which can provide up to $50 million in sales but does not obligate the company to sell shares. The extension supports Tevogen's strategy to remain selective and disciplined in financing while advancing its integrated healthcare model combining biopharma, AI, and healthcare services to improve medicine affordability and access.
Tevogen Inc.'s loan agreement extension allows borrowing up to $28.6 million through May 2029. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 09, 2026 19:41 WIB: out of 150 priced US health stocks, 121 rose and 18 fell today. Notable movers include Immunovant Inc. (IMVT) up 9.73% at USD 33.50, Inovio Pharmaceuticals Inc. (INO) up 8.64% at USD 1.32, and Cassava Sciences Inc. (FLNA) up 5.94% at USD 0.48, with typical hold times on Pluang ranging from 17 to 41 days.
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
